ESR1 and breast cancer: Since estrogen-dependent breast cancer MCF-7 cells were proposed to be more sensitive to compound 8, the estrogen receptor (ER) dependence of petromurin C (8) cytotoxicity to estrogen-dependent MCF-7 cells was investigated using 4-hydroxytamoxifen (4-OHT) as an ERs antagonist.